Clofarabine
Showing 1 - 25 of 172
Acute Myeloid Leukemia in Remission Trial in France (Fludarabine, Busulfan, ATG)
Not yet recruiting
- Acute Myeloid Leukemia in Remission
- Fludarabine
- +3 more
-
Nantes, Loire Atlantique, France
- +22 more
Jun 15, 2023
Metastatic Cancer, Carcinoma, Adenocarcinoma Trial in Cleveland (18F-Clofarabine)
Recruiting
- Metastatic Cancer
- +2 more
-
Cleveland, OhioCleveland Clinic, Case Comprehensive Cancer Center
May 11, 2022
Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphocytic Leukemia Trial in Boston (Antithymocyte Globulin,
Active, not recruiting
- Acute Myeloid Leukemia
- +6 more
- Antithymocyte Globulin
- Clofarabine
-
Boston, Massachusetts
- +1 more
Jan 25, 2022
Leukemia, Lymphoblastic, Acute, Pediatric Trial in United States (clofarabine (IV formulation))
Completed
- Leukemia, Lymphoblastic, Acute, Pediatric
- clofarabine (IV formulation)
-
Los Angeles, California
- +13 more
May 26, 2022
MDS, Secondary Acute Myeloid Leukemia (AML) Trial in United States (Clofarabine)
Completed
- Myelodysplastic Syndromes
- Secondary Acute Myeloid Leukemia (AML)
- Clofarabine
-
Chicago, Illinois
- +5 more
Mar 15, 2022
Clofarabine and Fludarabine Drug Exposure in Pediatric Bone
Completed
- Hematologic Malignancies
- +7 more
- Clofarabine
- Fludarabine Injection
-
San Francisco, CaliforniaUniversity of California, San Francisco
Sep 27, 2021
Adult Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult
Active, not recruiting
- Adult Acute Lymphoblastic Leukemia in Remission
- +6 more
- clofarabine
- +5 more
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 17, 2022
Disorder Related to Bone Marrow Transplantation, Leukemia, Transplantation Infection Trial in Houston (Fludarabine, Clofarabine,
Completed
- Disorder Related to Bone Marrow Transplantation
- +2 more
- Fludarabine
- +6 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Nov 18, 2021
Minimal Residual Disease, Leukemia, Lymphoblastic, Acute, Leukemia, Myelogenous, Acute Trial in Charlotte, Seattle (Clofarabine,
Terminated
- Minimal Residual Disease
- +2 more
- Clofarabine
- +3 more
-
Charlotte, North Carolina
- +1 more
Oct 4, 2021
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Lymphoblastic Lymphoma Trial in Valhalla, Charlotte (Clofarabine,
Active, not recruiting
- Acute Lymphoblastic Leukemia
- +4 more
- Clofarabine
- Mitoxantrone
-
Valhalla, New York
- +1 more
Oct 29, 2021
Langerhans Cell Histiocytosis Trial in Canada, United States (Clofarabine)
Active, not recruiting
- Langerhans Cell Histiocytosis
- Clofarabine
-
Phoenix, Arizona
- +14 more
Mar 28, 2022
Acute Myeloid Leukemia, Pediatric Cancer Trial in Boston (Uproleselan, Fludarabine, Clofarabine)
Recruiting
- Acute Myeloid Leukemia
- Pediatric Cancer
- Uproleselan
- +3 more
-
Boston, Massachusetts
- +1 more
Oct 24, 2022
Myelogenous Leukemia, Acute Trial in Ramat Gan (Bisantrene, Fludarabine, Clofarabine)
Recruiting
- Myelogenous Leukemia, Acute
- Bisantrene
- +2 more
-
Ramat Gan, IsraelChaim Sheba Medical Center
Sep 21, 2021
Hematopoietic Cell Transplantation Recipient, Refractory B-Cell Non-Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in
Active, not recruiting
- Hematopoietic Cell Transplantation Recipient
- +3 more
- Allogeneic Bone Marrow Transplantation
- +10 more
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2022
Acute Lymphoblastic Leukemia Trial in Memphis (Prednisone, Vincristine, Daunorubicin, PEG-L-asparaginase, Erwinia
Completed
- Acute Lymphoblastic Leukemia
- Prednisone, Vincristine, Daunorubicin, PEG-L-asparaginase, Erwinia L-asparaginase, Doxorubicin, Cyclophosphamide, Cytarabine, Thioguanine
- Clofarabine, Methotrexate, Mercaptopurine, Dexamethasone, Etoposide, Dasatinib
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Jul 26, 2022
Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Allogeneic Hematopoietic Stem Cell
Completed
- Acute Lymphoblastic Leukemia in Remission
- +6 more
- Allogeneic Bone Marrow Transplantation
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Dec 15, 2021
Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage Trial in Houston (Clofarabine,
Recruiting
- Acute Bilineal Leukemia
- +7 more
- Clofarabine
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2022
Acute Myeloid Leukemia Trial in Singapore, United States (Cytarabine, Daunorubicin, Etoposide)
AML, ALL, MDS Trial in New York (Clofarabine, Fludarabine, Busulfan)
Recruiting
- AML
- +8 more
- Clofarabine
- +5 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
May 13, 2022
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Lund (Clofarabine for remission induction, Etoposide for remission
Completed
- Acute Lymphoblastic Leukemia
- Acute Myeloid Leukemia
- Clofarabine for remission induction
- +7 more
-
Lund, SwedenLund University Hospital
Feb 17, 2021
Acute Myeloid Leukemia, Myelodysplastic Syndrome, Chronic Myeloid Leukemia Trial in Houston (Clofarabine, Busulfan, Fludarabine)
Completed
- Acute Myeloid Leukemia
- +2 more
- Clofarabine
- +5 more
-
Houston, TexasUT MD Anderson Cancer Center
Jan 6, 2021
Acute Myeloid Leukemia, Myelodysplastic Syndrome, Chronic Myeloid Leukemia Trial in Houston (Clofarabine 40mg/m^2, Idarubicin
Completed
- Acute Myeloid Leukemia
- +2 more
- Clofarabine 40mg/m^2
- +5 more
-
Houston, TexasUT MD Anderson Cancer Center
Dec 3, 2020
Autoimmune Disease, Crohn Disease, Inflammatory Disorder Trial in Los Angeles (Computed Tomography, Fluorine F 18 Clofarabine,
Completed
- Autoimmune Disease
- +5 more
- Computed Tomography
- +2 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Sep 2, 2020